BY
DR OLUWATOSIN AKANDE
Introduction
A child who does not respond to his name by the age of two is, in many Nigerian households, simply thought to be stubborn, spoilt, or “slow to talk.” By the time that same child receives a clinical diagnosis of autism spectrum disorder, the window in which intervention could have reshaped his developmental trajectory has often narrowed considerably. This is not because Nigerian parents love their children less carefully than parents elsewhere, nor because Nigerian clinicians are less skilled. It is because diagnosis and treatment in Nigeria are filtered through a socioeconomic sieve that determines, long before any clinical assessment takes place, who gets seen, who gets believed, and who gets helped. The question this essay poses is deliberately uncomfortable: in a country where a child’s neurodevelopmental future can be predicted almost as reliably by household income as by any biological marker, can early autism diagnosis ever be considered a genuine right rather than a private privilege? This essay argues that socioeconomic disadvantage in Nigeria operates at every stage of the autism care pathway, from the recognition of early signs to the sustaining of long-term intervention, and that meaningful progress will require Nigeria to treat autism not merely as a medical condition but as a development and equity issue demanding structural, not charitable, solutions.
The Silent Majority: Understanding Autism and the Case for Early Diagnosis
Autism spectrum disorder is a lifelong neurodevelopmental condition characterised by differences in social communication, alongside restricted or repetitive patterns of behaviour and interest. Its expression varies enormously from one child to another, which is precisely why it is described as a spectrum rather than a single fixed profile. What is not contested, however, is the evidence that timing matters enormously. Children who receive structured, evidence-based intervention before school age tend to show markedly better outcomes in communication, adaptive functioning and long-term independence than those whose support begins later (Aderinto et al., 2023). Standardised tools such as the Modified Checklist for Autism in Toddlers and the Autism Diagnostic Observation Schedule have transformed how quickly and accurately clinicians in well-resourced settings can identify autism, often before a child’s third birthday. Researchers in Nigeria have laboured to adapt these tools to the local context, producing instruments such as the Nigerian Autism Screening Questionnaire, validated specifically for use by caregivers who may have little formal education and who interact with the health system very differently from parents in high-income countries (Bakare et al., 2022). The existence of such tools proves that clinical capacity is not, on its own, the binding constraint. The binding constraint is whether a family can ever bring their child into contact with the systems in which these tools are used at all.
Nigeria’s Diagnostic Landscape: Progress Amid Persistent Gaps
Nigeria’s engagement with autism as a recognised clinical and social concern is comparatively recent, and the evidence base, while growing, remains thin relative to the size of the population it must serve. Reviews of the Nigerian literature consistently note that autism research from the country represents a strikingly small share of the continent’s overall output, even though Nigeria’s population dwarfs that of most neighbouring states (Adams, 2024). This is compounded by a policy environment in which developmental disorders receive negligible attention: budgetary analyses of Nigeria’s national appropriations have found that the word “autism” is barely mentioned across an entire fiscal document, let alone reflected in dedicated funding lines (Dataphyte Insight, 2025). Without political visibility, there is little incentive to build the surveillance systems, workforce training programmes or referral pathways that would allow early signs of autism to be caught as a matter of routine practice rather than fortunate accident. Clinical case series from Nigerian hospitals illustrate the consequence starkly: children referred to specialist centres tend to arrive years after their symptoms first emerged, frequently only after unsuccessful attempts to interpret their difficulties through spiritual, religious or purely behavioural explanations (Adams, 2024). Diagnosis, in this sense, is not simply delayed by ignorance. It is delayed by a health architecture that has not yet been built to notice.
The scale of the problem is difficult to state with confidence precisely because the data infrastructure needed to measure it properly barely exists. Estimates of autism prevalence among Nigerian children vary enormously depending on whether they are drawn from hospital records or community surveys, ranging from around one per cent in some school-based samples to figures many times higher in others, a spread that reflects differences in methodology as much as any genuine variation in underlying rates (Folorunso, 2025). Hospital-based studies, almost by definition, capture only the children whose families were able to reach a hospital in the first place, meaning that the very data Nigeria relies upon to plan its response is itself shaped by the socioeconomic filter this essay describes. A national picture built largely from urban, tertiary-hospital samples will systematically under-count rural and poorer children, not because autism is rarer among them, but because they are less visible to the systems doing the counting. This is a sobering illustration of how inequality can hide itself inside the very statistics meant to reveal it, and it should give policymakers pause before treating existing prevalence figures as a reliable guide to where resources are actually needed.
Socioeconomic Barriers to Early Identification
It is tempting to treat late diagnosis as a purely cultural or educational failing, easily solved by an awareness campaign or two. The evidence suggests something more structural. Case series of children diagnosed with autism in private Nigerian clinics have found that the overwhelming majority of those who do reach a diagnosis belong to higher socioeconomic households, a pattern that says less about who develops autism and far more about who can access the specialists capable of recognising it. Families in rural areas face a particularly punishing combination of disadvantages: an absence of nearby developmental paediatricians, psychologists or speech therapists; the cost and difficulty of travelling to the handful of urban centres where such specialists are concentrated; and cultural environments in which stigma discourages open discussion of a child’s difficulties in the first place (Aderinto et al., 2023). Nigeria’s own national health data illustrate how this disadvantage is not unique to autism but reflects a wider pattern in maternal and child health, where rural and northern households consistently report the weakest access to antenatal, postnatal and paediatric services, and where a large share of the population continues to live in conditions of multidimensional poverty that constrain their ability to seek any specialist care at all (Oweibia et al., 2025). When a family must weigh the cost of a diagnostic assessment against the cost of a term’s school fees or a month’s food supply, the assessment routinely loses. Even where free or subsidised screening exists, it tends to be concentrated in teaching hospitals in Lagos, Abuja, Ibadan and a small number of other cities, meaning that geography and income compound one another: the poorest families are disproportionately those furthest, in both distance and money, from the services that could identify their child’s needs early.
There is a further, more insidious dimension to this inequality. Diagnosis of autism in low-resource settings depends heavily on caregivers noticing and reporting developmental differences, since routine developmental surveillance is not embedded into most primary healthcare visits. Caregivers with limited formal education, who may already be sceptical of biomedical explanations for behaviours attributed to temperament or discipline, are less likely to flag concerns during the rare clinic visits they can afford, and are less likely to be believed when they do (Azubuike et al., 2024). Research among Nigerian caregivers of autistic children documents profound emotional distress, disbelief and confusion at the point of diagnosis, feelings intensified by the fact that many families had already spent years being told, often by trusted community or religious figures, that nothing was clinically wrong (Azubuike et al., 2024). Socioeconomic disadvantage therefore acts twice over: once by restricting physical and financial access to diagnostic services, and again by shaping whose concerns are taken seriously once inside them.
The Price of Intervention: Therapy as a Luxury Good
If diagnosis is difficult to reach, intervention is harder still to sustain. Evidence-based treatment for autism typically requires a combination of speech and language therapy, occupational therapy and behavioural intervention delivered consistently over months or years, not as a single course of treatment but as an ongoing therapeutic relationship. In Nigeria, this level of sustained care is priced well beyond the reach of most households. Reports from Lagos teaching hospitals describe individual therapy sessions costing several thousand naira each, with families required to pay separately for speech, occupational and behavioural therapy on a weekly basis, a financial burden that accumulates rapidly over a school term (Guardian Nigeria, 2026). Broader estimates of the annual cost of raising a child with autism in Nigeria place the figure well above the national minimum wage, a gap that all but guarantees that only the wealthiest families can access anything approaching the recommended intensity of intervention (Guardian Nigeria, 2026). For a family already living close to subsistence, sustained therapy is not a difficult choice; it is simply not a choice available at all.
The consequences of this financial exclusion are not evenly distributed by chance. Families who cannot afford private therapy are pushed towards an already overstretched public and tertiary system, in which autism services are rarely integrated into primary healthcare and are instead concentrated in a small number of specialist centres far from where most Nigerian children live (Guardian Nigeria, 2026). This forces families to choose between abandoning intervention altogether, relying on informal or unproven remedies, or undertaking journeys and expenses that jeopardise other essential household needs. Encouragingly, researchers have begun testing lower-cost alternatives suited to precisely these constraints. A randomised controlled trial conducted in Kano demonstrated that parent-mediated play interventions, in which caregivers themselves are trained to deliver therapeutic activities at home, produced meaningful improvements in children’s social communication without requiring the ongoing presence of costly specialist staff (Eseigbe et al., 2023). Such models matter because they shift the economic logic of intervention: instead of treating therapy as a service that must be purchased repeatedly from a scarce professional class, they treat the caregiver as a legitimate and capable agent of change, provided they receive adequate training and support. The scalability of this approach across Nigeria’s diverse regions remains to be proven, but it represents precisely the kind of contextually grounded innovation that socioeconomic reality demands.
Stigma, Awareness and the Weight of Culture
Poverty does not operate in isolation from culture; the two reinforce one another in ways that deepen the socioeconomic penalty attached to autism. Stigma surrounding neurodevelopmental disability remains widespread in Nigeria, where autism is sometimes attributed to spiritual causes, maternal wrongdoing or ancestral curses rather than understood as a neurological condition (Adams, 2024). Families who hold higher social status or greater education may be better positioned to resist or reinterpret these narratives, and better able to seek a second opinion when a first explanation feels unsatisfactory. Poorer families, with fewer social and informational resources to draw upon, are more vulnerable to accepting the first explanation offered, however unhelpful, simply because seeking further opinions costs money and time they do not have. Caregiving itself then becomes an economic burden layered on top of the diagnostic one: mothers, who bear the overwhelming share of caregiving responsibility in most Nigerian households, frequently report having to reduce paid work or abandon income-generating activity altogether in order to manage a child’s needs, entrenching the very poverty that made diagnosis and treatment difficult to access in the first place (Azubuike et al., 2024). This is the cruel circularity at the heart of the issue: socioeconomic disadvantage delays diagnosis, delayed diagnosis worsens outcomes, and worsened outcomes increase the caregiving burden that, in turn, deepens the family’s socioeconomic disadvantage.
Rethinking the System: Pathways Towards Equity
None of this is to suggest that the situation is beyond remedy. Nigerian researchers and clinicians have already generated several promising avenues, though each requires a level of political and financial commitment that has so far been lacking. First, task-shifting models that train non-specialist health workers, teachers and community volunteers to conduct basic developmental screening could dramatically expand the reach of early identification beyond the handful of urban specialist centres currently carrying almost the entire national caseload. Locally validated tools such as the Nigerian Autism Screening Questionnaire and adapted versions of instruments like the Social Communication Questionnaire have already demonstrated that culturally appropriate, caregiver-report screening is both feasible and psychometrically sound in the Nigerian context (Bakare et al., 2022; Nwokolo et al., 2024), yet they remain confined largely to research settings rather than integrated into routine primary healthcare contact points such as immunisation clinics, where the vast majority of Nigerian children, regardless of income, are still brought at least occasionally.
Second, the parent-mediated intervention model piloted in Kano suggests a template for delivering meaningful therapeutic support without requiring families to bear the full cost of specialist labour (Eseigbe et al., 2023). Scaling such models through community health workers, non-governmental organisations and special needs schools could bring intervention within reach of households who will never be able to afford weekly private therapy sessions. Third, budgetary visibility matters more than is often acknowledged: the near-total absence of autism from national fiscal planning signals to health administrators, insurers and educators alike that this is not a public priority (Dataphyte Insight, 2025). Bringing autism explicitly into national health insurance schemes, disability legislation enforcement, and early childhood development budgets would begin to shift the financial burden away from individual households and towards the shared responsibility of the state. Finally, addressing stigma requires more than isolated awareness days; it requires sustained public health messaging embedded within trusted community and religious structures, precisely the institutions currently most likely to offer alternative, non-clinical explanations for a child’s difficulties (Adams, 2024).
Conclusion: A Question of National Will
The story of autism in Nigeria is, at its core, a story about who a society decides is worth noticing early. The clinical knowledge required to identify and support autistic children exists; Nigerian researchers have proven this through the tools and interventions they have painstakingly validated for their own population. What remains absent is the political and financial architecture needed to make that knowledge reach every child regardless of the wealth of the household into which they were born. A nation’s commitment to its children is measured not only by the interventions it can offer to those who can pay for them, but by how quickly it notices, and how seriously it takes, the quiet child in a household that cannot. Until early screening is woven into the ordinary fabric of primary healthcare, and until intervention is financed as a public good rather than sold as a private luxury, socioeconomic status will continue to determine, more than any clinical judgement, which Nigerian children with autism are given a genuine chance to thrive.
References
Adams, S. N. (2024). The unmasking of autism in South Africa and Nigeria. Neuropsychiatric Disease and Treatment, 20, 947–955. https://doi.org/10.2147/NDT.S461650
Aderinto, N., Olatunji, D., & Idowu, O. (2023). Autism in Africa: Prevalence, diagnosis, treatment and the impact of social and cultural factors on families and caregivers: A review. Annals of Medicine & Surgery, 85(9), 4410–4416. https://doi.org/10.1097/MS9.0000000000001107
Azubuike, A. O., Azubuike, P. C., Onyekachi, E. L., Enyam, M. O., Akinreni, T., Abuo, J., Ogbonna, C. K., Timothy, P. N., Uchegbu, E. R., & Adai, G. S. (2024). Experiences and unmet needs among caregivers of children living with autism spectrum disorder in Nigeria: A qualitative study using the socio-ecological model. Discover Social Science and Health, 4(1), Article 77. https://doi.org/10.1007/s44155-024-00141-w
Bakare, M. O., Frazier, T. W., Karpur, A., Abubakar, A., Nyongesa, M. K., Mwangi, P. M., Dixon, P., Khaliq, I., Gase, N. K., Sandstrom, J., Okidegbe, N., Rosanoff, M., Munir, K. M., & Shih, A. (2022). Brief report: Validity and reliability of the Nigerian Autism Screening Questionnaire. Autism, 26(6), 1575–1582. https://doi.org/10.1177/13623613221080250
Dataphyte Insight. (2025, April 6). World Autism Day: The data, research, and budget gaps on autism support in Nigeria. Dataphyte. https://dataphyte.com/issue/data-dives/2025/04/world-autism-day-the-data-research-and-budget-gaps-on-autism-support-in-nigeria
Eseigbe, E. E., Nuhu, F. T., & Sheikh, T. L. (2023). Effectiveness of parent-mediated play interventions for young children with autism spectrum disorder in low-resource settings: A randomised controlled trial in Kano, Nigeria. Autism Research, 16(4), 801–812. https://doi.org/10.1002/aur.2891
Folorunso, A. (2025). Autism spectrum disorder among Nigerian children ages 2–17: Prevalence, awareness, advocacy and legislative action scoping review [Unpublished master’s dissertation, Liverpool John Moores University]. Research Square. https://doi.org/10.21203/rs.3.rs-6735926/v1
Guardian Nigeria. (2026, April 2). World Autism Day: Scarce services, high cost of care deepen financial strain on households. https://guardian.ng/news/world-autism-day-scarce-services-high-cost-of-care-deepen-financial-strain-on-households/
Nwokolo, E. U., Murphy, G. H., & Langdon, P. E. (2024). Validation of the Social Communication Questionnaire amongst Nigerian adolescents. Autism Research, 17(1), 66–77. https://doi.org/10.1002/aur.3038
Olusanya, B. O., Wright, S. M., Nair, M. K. C., Boo, N. Y., Halpern, R., Kancherla, V., Smythe, T., Kakooza-Mwesige, A., Ogbo, F. A., Olusanya, J. O., Ott, W. J., Croft, T. N., & Wehrmeister, F. C. (2022). Global burden of childhood epilepsy, intellectual disability, and sensory impairments: Systematic analysis of disease burden in Nigeria. The Lancet Global Health, 10(3), e390–e398. https://doi.org/10.1016/S2214-109X(21)00549-0
Oweibia, M., Elemuwa, C. O., Egberipou, T., Timighe, G. C., Sylvanus, P., & Wilson, T. R. (2025). Maternal and child health trends in Nigeria: A scoping review of NDHS 2018 vs. NDHS 2023 [Preprint]. medRxiv. https://doi.org/10.1101/2025.05.18.25327864
